Jennifer Tullai

Novartis (United States) — United States

Medicine · Health Sciences

11h-index675citations19works16.52yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Erythropoietin and Anemia Treatment(6), Erythrocyte Function and Pathophysiology(4), Protein Degradation and Inhibitors(4), Biosimilars and Bioanalytical Methods(3), Computational Drug Discovery Methods(2)

Publications19 total

A small-molecule VHL molecular glue degrader for cysteine dioxygenase 1
Nature Chemical Biology·2025· 19 cited
A small molecule VHL molecular glue degrader for cysteine dioxygenase 1
2024· 14 citedOpen Access
Discovery and characterization of a selective IKZF2 glue degrader for cancer immunotherapy
Cell chemical biology·2023· 136 citedOpen Access
Targeted degradation of IKZF2 for cancer immunotherapy
2022· 1 citedOpen Access
Abstract 2025: Characterization of cancer cell lines made senescent by exposure to ribociclib, doxorubicin, or TGFβ1, and identification of genes required for entry into senescence and senescent cell survival
Cancer Research·2021· 2 cited
Englerin A Agonizes the TRPC4/C5 Cation Channels to Inhibit Tumor Cell Line Proliferation
PLoS ONE·2015· 108 citedOpen Access
Peptide mimetics of erythropoietin are powerful probes of receptor activation mechanisms
Kluwer Academic Publishers eBooks·2006· 1 cited
Recombinant epoetins do not stimulate tumor growth in erythropoietin receptor–positive breast carcinoma models
Molecular Cancer Therapeutics·2006· 81 citedOpen Access
Erythropoietic Therapy Does Not Stimulate Tumor Growth in Erythropoietin Receptor (EPOR)-Positive MDA-MB-231 and MCF-7 Breast Carcinoma Models.
Blood·2005· 2 cited
The role of erythropoietin (EPO) in angiogenesis and tumorigenesis
Cancer Research·2005
Erythropoietin Did Not Activate the JAK/STAT or the ERK1/2 Pathway in the Human Colorectal Cell Line, HT-29.
Blood·2004· 2 cited
A peptide mimetic of erythropoietin: Critical residues and description of a minimal functional epitope
2002
Synthesis and erythropoietin receptor binding affinities of N,N-disubstituted amino acids
Bioorganic & Medicinal Chemistry Letters·2000· 8 citedOpen Access
Shared and Unique Determinants of the Erythropoietin (EPO) Receptor Are Important for Binding EPO and EPO Mimetic Peptide
Journal of Biological Chemistry·1999· 60 citedOpen Access
Identification of a 13 Amino Acid Peptide Mimetic of Erythropoietin and Description of Amino Acids Critical for the Mimetic Activity of EMP1
Biochemistry·1998· 101 cited
Amino-terminal dimerization of an erythropoietin mimetic peptide results in increased erythropoietic activity
Chemistry & Biology·1997· 55 citedOpen Access
Mutagenesis Studies of the Human Erythropoietin Receptor
Journal of Biological Chemistry·1997· 17 citedOpen Access
Identification of a Critical Ligand Binding Determinant of the Human Erythropoietin Receptor
Journal of Biological Chemistry·1996· 55 citedOpen Access
Interleukin-3/erythropoietin fusion proteins: in vitro effects on hematopoietic cells.
PubMed·1993· 13 cited

Frequent Co-authors

Francis X. Farrell(10), Linda K. Jolliffe(10), Dana L. Johnson(8), Frank J. McMahon(8), Jonathan M. Solomon(6), Francis P. Barbone(6), Steven A. Middleton(6), Linda S. Mulcahy(5), Rohan E. J. Beckwith(4), Aleem Fazal(4), Jennifer Cobb(4), Xiaolei Ma(4), Charles Wartchow(4), Oded Livnah(4), Ian A. Wilson(4), Ze’ev Gechtman(4), Rishi K. Jain(3), E.A. Stura(3), Kenneth R. LaMontagne(3), Jeannene Butler(3)